Pascoe Richard W

Avg. Two Year Performance

(35%) Avg. Purchase Return
(16%) Compound
87% Avg. Sale Return
37% Compound
1 Mo3 Mo6 Mo1 Yr2 Yr
Average Purchase Return(9%)(15%)(21%)(22%)(35%)
Purchase Success Rate1 of 71 of 72 of 71 of 70 of 7
Average Sale Return(39%)(22%)14%37%87%
Sale Success Rate0 of 51 of 53 of 52 of 54 of 5

Somaxon Pharmaceuticals, Inc.

Drugs » Drug Manufacturers - Other

President and CEO, Director:

Holdings: 0 shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Histogen Inc.

Drugs » Biotechnology

President, CEO & Director, Director:

Holdings: 30.0K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Zevra Therapeutics, Inc.

Drugs » Biotechnology

Chief Executive Officer, Director:

Holdings: 29.97K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

Ariad Pharmaceuticals Inc.

Drugs » Biotechnology

Senior VP, COO:

Holdings: shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--

NexMed Inc.

Drugs » Drug Manufacturers - Other

Director:

Holdings: 155.4K shares

Sentiment

Insider Trading Sentiment: Hold

Avg. Two Year Performance

No purchase track record
No sale track record

Last Three Months:

0 Net Amount
Buy:0--
Sell:0--